Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Master Protocol for squamous cell lung cancer readies for launch

This article has been updated

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Change history

  • 29 May 2014

    In the version of this article initially published, Genentech's compound Taselisib was incorrectly labeled as Pictilisib in Table 1. The error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fox, J. Master Protocol for squamous cell lung cancer readies for launch. Nat Biotechnol 32, 116–117 (2014). https://doi.org/10.1038/nbt0214-116b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0214-116b

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer